Yifan Wu

709 total citations
45 papers, 366 citations indexed

About

Yifan Wu is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Yifan Wu has authored 45 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Epidemiology. Recurrent topics in Yifan Wu's work include Dialysis and Renal Disease Management (11 papers), Chronic Kidney Disease and Diabetes (8 papers) and Chronic Disease Management Strategies (5 papers). Yifan Wu is often cited by papers focused on Dialysis and Renal Disease Management (11 papers), Chronic Kidney Disease and Diabetes (8 papers) and Chronic Disease Management Strategies (5 papers). Yifan Wu collaborates with scholars based in China, Sweden and United States. Yifan Wu's co-authors include Xusheng Liu, Suyuan Peng, Jiawei He, Zhang La, Shan Zeng, Jiahao Zeng, Fang Tang, Lili Hou, Huifen Chen and Cheng‐Di Dong and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Yifan Wu

40 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifan Wu China 12 126 63 41 38 36 45 366
Alaleh Gheissari Iran 12 159 1.3× 35 0.6× 67 1.6× 49 1.3× 19 0.5× 49 462
Joseph J. Deferio United States 11 144 1.1× 67 1.1× 35 0.9× 26 0.7× 20 0.6× 14 420
Mary Hannan United States 9 175 1.4× 37 0.6× 31 0.8× 105 2.8× 36 1.0× 27 351
Nigar Sekercioglu Canada 14 172 1.4× 34 0.5× 82 2.0× 68 1.8× 46 1.3× 36 495
Betty Chui Canada 7 263 2.1× 49 0.8× 35 0.9× 36 0.9× 52 1.4× 7 480
Helga Gudmundsdottir Norway 13 94 0.7× 39 0.6× 43 1.0× 162 4.3× 25 0.7× 25 381
Sarah Davies United Kingdom 9 82 0.7× 36 0.6× 43 1.0× 40 1.1× 42 1.2× 18 325
Filipe Ferrari Brazil 12 65 0.5× 29 0.5× 38 0.9× 100 2.6× 13 0.4× 44 400
Bård Waldum Norway 10 181 1.4× 81 1.3× 45 1.1× 152 4.0× 36 1.0× 12 415
Shufang Jiao China 7 174 1.4× 68 1.1× 30 0.7× 96 2.5× 22 0.6× 12 426

Countries citing papers authored by Yifan Wu

Since Specialization
Citations

This map shows the geographic impact of Yifan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifan Wu more than expected).

Fields of papers citing papers by Yifan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifan Wu. The network helps show where Yifan Wu may publish in the future.

Co-authorship network of co-authors of Yifan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yifan Wu. A scholar is included among the top collaborators of Yifan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifan Wu. Yifan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Huifen, Fang Tang, Gaetano Marrone, et al.. (2025). Dietary quality and adherence to dietary recommendations in Chinese patients with chronic kidney disease. Frontiers in Nutrition. 12. 1547181–1547181. 1 indexed citations
2.
Chen, Yiqin, Yan Han, Yidan Zhang, et al.. (2025). Lower phase angle as a marker for poor prognosis in patients with chronic kidney disease: a cohort study. Frontiers in Nutrition. 12. 1580037–1580037.
3.
Liang, Jin‐Hua, Yifan Wu, Yue Li, et al.. (2024). Clinical Implications of CSF-Ctdna Positivity in Newly Diagnosed Diffuse Large B Cell Lymphoma in a Large Cohort. Blood. 144(Supplement 1). 576–576. 1 indexed citations
4.
Liang, Jin‐Hua, Yifan Wu, Yue Li, et al.. (2024). Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. Leukemia. 38(7). 1541–1552. 6 indexed citations
5.
Wu, Yifan, Hua Wei, Rui Gao, et al.. (2024). Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms. Cell Communication and Signaling. 22(1). 401–401.
6.
Liu, Xiao, J. Zhang, Yifan Wu, et al.. (2024). Association between influenza vaccination and prognosis in patients with ischemic heart disease: A systematic review and meta-analysis of randomized controlled trials. Travel Medicine and Infectious Disease. 64. 102793–102793. 3 indexed citations
7.
Wang, Wei‐Ting, Hua Wei, Yifan Wu, et al.. (2024). CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy. Cancer Letters. 583. 216616–216616. 12 indexed citations
8.
Chen, Ming, et al.. (2023). Development and validation of the Perceived Benefits of Team-Interaction Training Questionnaire (PBTITQ) among undergraduates. BMC Medical Education. 23(1). 840–840. 2 indexed citations
9.
10.
Zhang, Xianlong, Xueyi Xu, Min Zhang, et al.. (2022). Machine learning algorithms’ accuracy in predicting kidney disease progression: a systematic review and meta-analysis. BMC Medical Informatics and Decision Making. 22(1). 205–205. 20 indexed citations
11.
Zhang, Yanmei, Lu Zeng, Yin Chen, et al.. (2022). The efficacy and safety of self-administered acupressure on respiratory tract infection in chronic kidney disease: a randomized controlled trial. Annals of Translational Medicine. 10(12). 688–688. 1 indexed citations
12.
Xu, Yan‐Min, et al.. (2021). Is E-Version Transition of the Medication Adherence Scale Feasible for CKD Management? A Pilot Study. Patient Preference and Adherence. Volume 15. 1785–1793.
13.
Huang, Qiong, Li Luo, Cheng‐Di Dong, et al.. (2020). <p>Refinement and Evaluation of a Chinese and Western Medication Adherence Scale for Patients with Chronic Kidney Disease: Item Response Theory Analyses</p>. Patient Preference and Adherence. Volume 14. 2243–2252. 4 indexed citations
14.
Luo, Li, Huifen Chen, Cheng‐Di Dong, et al.. (2019). <p>A Chinese and Western medication adherence scale in patients with Chronic Kidney Disease</p>. Patient Preference and Adherence. Volume 13. 1487–1495. 29 indexed citations
15.
Wu, Yifan, Lin Li, Hong Ren, et al.. (2019). New risk score for predicting progression of membranous nephropathy. Journal of Translational Medicine. 17(1). 41–41. 23 indexed citations
16.
Zhang, Min, Suyuan Peng, Qiong Huang, et al.. (2018). Chronic Kidney Disease Medication Adherence and its Influencing Factors: An Observation and Analysis. 8. 1959–1966. 1 indexed citations
17.
18.
19.
Wu, Yifan, Yin Li, Fuhua Lu, et al.. (2014). The effect of coix seed on the nutritional status of peritoneal dialysis patients: A pilot study. Complementary Therapies in Medicine. 22(1). 40–48. 11 indexed citations
20.
Wu, Yifan, et al.. (2014). Management of chronic kidney disease in china calls for the implementation of expert patient program with traditional Chinese medical interventions. Chinese Journal of Integrative Medicine. 20(10). 796–800. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alaleh Gheissari Breakdown of academic impact, for papers by Joseph J. Deferio Breakdown of academic impact, for papers by Mary Hannan Breakdown of academic impact, for papers by Nigar Sekercioglu Breakdown of academic impact, for papers by Betty Chui Breakdown of academic impact, for papers by Helga Gudmundsdottir Breakdown of academic impact, for papers by Sarah Davies Breakdown of academic impact, for papers by Filipe Ferrari Breakdown of academic impact, for papers by Bård Waldum Breakdown of academic impact, for papers by Shufang Jiao
Rankless by CCL
2026